Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)

JA Radford; AZS Rohatiner; WDJ Ryder; DP Deakin; T Barbui; N Lucie; A Rossi; DJ Dunlop; RD James; RK Gupta; RA Cowan; J Shamash; J Chang; TA Lister

Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)

JA Radford, AZS Rohatiner, WDJ Ryder, DP Deakin, T Barbui, N Lucie, A Rossi, DJ Dunlop, RD James, RK Gupta, RA Cowan, J Shamash, J Chang, TA Lister

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	18
Number of pages	1
Journal	British Journal of Cancer
Volume	80
Publication status	Published - 1999

Cite this

@article{3c680df00c80411cb41c1d1867e50f63,

title = "Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)",

author = "JA Radford and AZS Rohatiner and WDJ Ryder and DP Deakin and T Barbui and N Lucie and A Rossi and DJ Dunlop and RD James and RK Gupta and RA Cowan and J Shamash and J Chang and TA Lister",

year = "1999",

language = "English",

volume = "80",

pages = "18",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)

AU - Radford, JA

AU - Rohatiner, AZS

AU - Ryder, WDJ

AU - Deakin, DP

AU - Barbui, T

AU - Lucie, N

AU - Rossi, A

AU - Dunlop, DJ

AU - James, RD

AU - Gupta, RK

AU - Cowan, RA

AU - Shamash, J

AU - Chang, J

AU - Lister, TA

PY - 1999

Y1 - 1999

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000081955000064&KeyUID=WOS:000081955000064

M3 - Article

SN - 0007-0920

VL - 80

SP - 18

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -

Fourteen years clinical trial experience with the ChlVPP/EVA hybrid regimen as first line treatment for advanced Hodgkin's disease (HD)

Other files and links

Cite this